{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:40:50Z","timestamp":1760146850888,"version":"build-2065373602"},"reference-count":6,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>RNA therapeutics are a class of medicines based on the insertion of a specific genetic message (mRNA) into the cells and the silencing or gene editing of a specific mRNA [...]<\/jats:p>","DOI":"10.3390\/pharmaceutics16121590","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T03:51:08Z","timestamp":1734061868000},"page":"1590","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Editorial on Special Issue \u201cState-of-Art in mRNA Therapeutics and Gene Delivery\u201d"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0218-9690","authenticated-orcid":false,"given":"Liliana S.","family":"Mendon\u00e7a","sequence":"first","affiliation":[{"name":"Center for Neuroscience and Cell Biology, University of Coimbra, 3004-504 Coimbra, Portugal"},{"name":"Center for Innovative Biomedicine and Biotechnology, University of Coimbra, 3004-504 Coimbra, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Silas, D.S., Juneja, B., Kaur, K., Narayanareddy Gari, M., You, Y., Moon, Y., Chen, Y., Arora, S., Hansen, J., and Muthusamy, K. (2024). Development of Biolayer Interferometry (BLI)-Based Double-Stranded RNA Detection Method with Application in mRNA-Based Therapeutics and Vaccines. Pharmaceutics, 16.","DOI":"10.3390\/pharmaceutics16091227"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Marin-Muller, C., Li, M., L\u00fc, J.M., Liang, Z., Vega-Mart\u00ednez, O., Crawford, S.E., Estes, M.K., Fisher, W.E., Chen, C., and Yao, Q. (2023). Nanoparticle-Mediated Therapy with miR-198 Sensitizes Pancreatic Cancer to Gemcitabine Treatment through Downregulation of VCP-Mediated Autophagy. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15082038"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Campeiro, J.D., Dam, W.A., Hayashi, M.A.F., and Born, J.v.D. (2023). Crotamine\/siRNA Nanocomplexes for Functional Downregulation of Syndecan-1 in Renal Proximal Tubular Epithelial Cells. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15061576"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Valenzuela, A., Ayuso, M., Buyssens, L., Bars, C., Van Ginneken, C., Tessier, Y., and Van Cruchten, S. (2023). Platelet Activation by Antisense Oligonucleotides (ASOs) in the G\u00f6ttingen Minipig, including an Evaluation of Glycoprotein VI (GPVI) and Platelet Factor 4 (PF4) Ontogeny. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15041112"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Yavuz, A., Coiffier, C., Garapon, C., Gurcan, S., Monge, C., Exposito, J.-Y., Arruda, D.C., and Verrier, B. (2023). DLin-MC3-Containing mRNA Lipid Nanoparticles Induce an Antibody Th2-Biased Immune Response Polarization in a Delivery Route-Dependent Manner in Mice. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15031009"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Safiullov, Z., Izmailov, A., Sokolov, M., Markosyan, V., Kundakchan, G., Garifulin, R., Shmarov, M., Naroditsky, B., Logunov, D., and Islamov, R. (2022). Autologous Genetically Enriched Leucoconcentrate in the Preventive and Acute Phases of Stroke Treatment in a Mini-Pig Model. Pharmaceutics, 14.","DOI":"10.3390\/pharmaceutics14102209"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/12\/1590\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:53:57Z","timestamp":1760115237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/16\/12\/1590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":6,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["pharmaceutics16121590"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics16121590","relation":{},"ISSN":["1999-4923"],"issn-type":[{"type":"electronic","value":"1999-4923"}],"subject":[],"published":{"date-parts":[[2024,12,13]]}}}